Company page

Mendus Ab

Mendus Ab is a public company traded under the ticker IMMU on the Swedish market. The company has a market capitalization of approximately 37.14 million USD. Mendus Ab focuses on developing innovative immunotherapies to treat cancer, aiming to improve patient outcomes through advanced medical solutions.